Sitagliptin Phosphate Anhydrous (process-ii)
Generic Name: sitagliptin phosphate anhydrous (process-ii)
Dosage form: POWDER. Active ingredients: SITAGLIPTIN PHOSPHATE ANHYDROUS (50 kg/50kg). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: SITAGLIPTIN PHOSPHATE ANHYDROUS (50 kg/50kg). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Sodium Carbonate Monohydrate
sodium carbonate monohydrate
Dosage form: POWDER. Active ingredients: SODIUM CARBONATE MONOHYDRATE (1 kg/kg). Category: BULK INGREDIENT.
Nogapendekin Alfa Inbakicept-pmln
nogapendekin alfa inbakicept-pmln
11 DESCRIPTION Nogapendekin alfa inbakicept-pmln is an interleukin-15 (IL-15) receptor agonist. It is a soluble complex consisting of (a) nogapendekin alfa (a human IL-15N72D variant, 114 amino acids) bound to (b) inbakicept [a dimeric human IL-15Rα sushi domain (65 amino acids)/human IgG1 Fc fusion protein (232 amino acids)]. Each fully assembled nogapendekin alfa inbakicept-pmln complex consists of a single inbakicept and two nogapendekin alfa components.
Mgf (mechano Growth Factor) Acetate
mgf (mechano growth factor) acetate
Dosage form: POWDER. Active ingredients: MECASERMIN (1 g/g). Category: BULK INGREDIENT.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.